Addex Therapeutics ADXN 深 沪
等待开盘 10-01 09:30:00 美东时间
2.76
-0.190
-6.44%
华盛通- 最 高2.91
- 今 开2.91
- 成交量 4874股
- 最 低 2.67
- 昨 收 2.95
- 总市值 483.67万
- 52周最高 11.97
- 市盈率 静 --
- 换手率 0.28%
- 52周最低 2.56
- 委 比 51.46%
- 总股本 175.24万
- 历史最高 750.40
- 量 比 0.15
- 振 幅 8.14%
- 历史最低 0.00
- 每 手 1
- 风险率 1.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For September 28, 2026
Companies Reporting Before The Bell • Kandi Technologies Gr (NASDAQ:KNDI) is likely to report earnings for its first quarter. • Inventiva (NASDAQ:IVA) is expected to report quarterly loss at $0.20 per share on revenue of $10.00 million. • Addex Therapeutics (NASDAQ:ADXN) is likely to report earnings...
09-28 19:11
Addex Therapeutics reports 1H results
Addex Therapeutics press release (ADXN): 1H basic and diluted loss per share remained stable at CHF 0.03 per share for the six-month periods ended June 30, 2026 and 2025. Cash and cash equivalents dec...
09-28 15:46
Addex Therapeutics Q2 EPS $(1.52) Up From $(2.90) YoY, Sales $12.650K Down From $44.031K YoY
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.52) per share. This is a 47.59 percent increase over losses of $(2.90) per share from the same period last year. The company reported $12.650 thousand in sales this quarter. This is a 71.27 percent decrease over sales of $44.031 thous...
09-28 14:05
Addex Therapeutics shares are trading higher after the company announced it regained full global rights to all GABAB positive allosteric modulator assets discovered under its research collaboration with Indivior UK.
Addex Therapeutics shares are trading higher after the company announced it regained full global rights to all GABAB positive allosteric modulator assets discovered under its research collaboration with Indivior UK.
09-25 20:28
Addex Therapeutics raises $2.8M via ATM offering, extending runway to Q4 2027
Addex Therapeutics (ADXN) has raised $2.8M (CHF 2.2M) in gross proceeds through its At-the-Market (ATM) offering agreement with H.C. Wainwright & Co. The clinical-stage biopharmaceutical firm sold 437...
08-26 15:24
Addex Therapeutics Q1 EPS $(1.53) Down From $(1.33) YoY, Sales $10.214K Down From $78.928K YoY
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.53) per share. This is a 15.04 percent decrease over losses of $(1.33) per share from the same period last year. The company reported $10.214 thousand in sales this quarter. This is a 87.06 percent decrease over sales of $78.928 thous...
06-25 13:54
Addex Therapeutics Q4 2025 Earnings Call Transcript
Addex Therapeutics (NASDAQ:ADXN) held its fourth-quarter earnings conference ca...
04-30 22:52
Earnings Scheduled For April 30, 2026
Companies Reporting Before The Bell • Sonic Automotive (NYSE:SAH) is projected ...
04-30 19:11
Addex Therapeutics Q4 EPS $(1.50) Down From $(1.37) YoY, Sales $20.020K Up From $1.719K YoY
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.50) per share. This is a 9.49 percent decrease over losses of $(1.37) per share from the same period last year. The company reported $20.020 thousand in
04-30 15:59
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares moved upwards by 145.6%...
04-24 20:05
